News & Articles

The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR

Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic

New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s

Marcelo Shigueru Kamei shares how the latest chromatography solutions help his team at Cristália laboratory stay a step ahead as they manufacture quality pharma products

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days

The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens

The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C

Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19

Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results

The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein

Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season

The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients

The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts

Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test

Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions

Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology

Exclusive interviews, new methods, free downloads and more to help advance your pharma and biopharma research & development

Don't miss this webinar to find out how to maintain data integrity when documentin results in your paperless lab

Learn how a generics pharmaceutical company in the U.S. is simplifying chromatography data management for greater productivity

With near 30 years dedicated to the advancement of IMS, Excellims founder Dr. Ching Wu shares the story behind the first high-performance systems